FPRX

Five Prime Therapeutics, Inc.
FPRX

Overview Fund Activity
Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

137 hedge funds and large institutions have $573M invested in Five Prime Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 19 closing their positions.

Holders
137
Holders Change
+11
Holders Change %
+8.73%
% of All Funds
3.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
52
Reduced
31
Closed
19
Calls
$2.14M
Puts
$3.64M
Net Calls
-$1.5M
Net Calls Change
-$597K

Top Buyers

1
State Street
1
State Street
Massachusetts
$38.2M
2
DM
2
Deerfield Management
New York
$9.88M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$9.87M
4
Victory Capital Management
4
Victory Capital Management
Texas
$20.3M
5
Morgan Stanley
5
Morgan Stanley
New York
$7.71M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$28.5M
2
HM
2
HealthCor Management
New York
$2.21M
3
EAM
3
Eventide Asset Management
Massachusetts
$6.91M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$4.11M +$42K +1,915 +1%
DekaBank Deutsche Girozentrale
27
DekaBank Deutsche Girozentrale
Germany
$3.72M – – –
Goldman Sachs
28
Goldman Sachs
New York
$3.36M +$1.99M +90,810 +145%
ARTA
29
A.R.T. Advisors
New York
$3.34M +$2.79M +127,295 +510%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.29M -$1.65M -75,178 -33%
AIC
31
AWM Investment Company
New York
$3.29M +$1.1M +50,000 +50%
Two Sigma Investments
32
Two Sigma Investments
New York
$3.1M +$3.1M +141,268 New
Deutsche Bank
33
Deutsche Bank
Germany
$3.07M +$606K +27,655 +25%
Axa
34
Axa
France
$2.91M -$3.03K -138 -0.1%
Charles Schwab
35
Charles Schwab
California
$2.84M -$242K -11,044 -8%
IBT
36
International Biotechnology Trust
United Kingdom
$2.53M +$635K +29,000 +34%
HM
37
HealthCor Management
New York
$2.21M -$19.9M -909,930 -90%
RI
38
RTW Investments
New York
$2.2M +$2.2M +100,377 New
UBS AM
39
UBS AM
Illinois
$2.12M -$237K -10,832 -10%
Citadel Advisors
40
Citadel Advisors
Florida
$1.83M +$1.83M +83,284 New
CS
41
Candriam SCA
Luxembourg
$1.75M +$658K +30,000 +60%
GPCM
42
Granite Point Capital Management
Massachusetts
$1.75M +$658K +30,000 +60%
AGA
43
Altrinsic Global Advisors
Connecticut
$1.75M +$1.75M +80,000 New
Citigroup
44
Citigroup
New York
$1.55M +$987K +45,035 +176%
TCIM
45
TIAA CREF Investment Management
New York
$1.4M -$228K -10,378 -14%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$1.39M +$1.23M +56,100 +748%
PIM
47
Platinum Investment Management
Australia
$1.38M +$920K +42,000 +202%
VIA
48
Vident Investment Advisory
Georgia
$1.31M +$416K +18,994 +47%
TAM
49
Trillium Asset Management
Massachusetts
$1.29M -$129K -5,894 -9%
GC
50
Guggenheim Capital
Illinois
$1.28M -$222K -10,135 -15%
1
2
3 4 5